1921
Volume 86, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

For over 60 years, pentavalent antimony (Sb) has been the first-line treatment of leishmaniasis. Sickle cell anemia is a disease caused by a defect in red blood cells, which among other things can cause vasooclusive crisis. We report the case of a 6-year-old child with leishmaniasis who during treatment with meglumine antimoniate developed a sickle cell crisis (SCC). No previous reports describing the relationship between antimonial drugs and sickle cell disease were found. Reviews of both the pathophysiology of SCC and the mechanism of action of Sb revealed that a common pathway (glutathione) may have resulted in the SCC. ChemoText, a novel database created to predict chemical-protein-disease interactions, was used to perform a more expansive and systematic review that was able to support the association between glutathione, Sb, and SCC. Although suggestive evidence to support the hypothesis, additional research at the bench would be needed to prove Sb caused the SCC.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2012.11-0683
2012-06-01
2017-09-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/86/6/1057.html?itemId=/content/journals/10.4269/ajtmh.2012.11-0683&mimeType=html&fmt=ahah

References

  1. Saravia NG, Weigle K, Navas C, Segura I, Valderrama L, Valencia AZ, Escorcia B, McMahon-Pratt D, , 2002. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania viannia in Colombia. Am J Trop Med Hyg 66: 738744.
  2. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S, , 2007. Cutaneous leishmaniasis. Lancet Infect Dis 7: 581596.[Crossref]
  3. Ballas SK, , 2002. Sickle cell anaemia: progress in pathogenesis and treatment. Drugs 62: 11431172.[Crossref]
  4. Jaramillo M, Sáenz I, Pereira F, , 1997. Tamizaje para anemia de células falciformes en recién nacidos del Hospital Universitario del Valle y del Hospital Mario Correa Renjifo. Actual Pediatr (Granada) 7: 313.
  5. Baker NC, Hemminger BM, , 2010. Mining connections between chemicals, proteins, and diseases extracted from Medline annotations. J Biomed Inform 43: 510519.[Crossref]
  6. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH, , 1982. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 70: 12531259.[Crossref]
  7. Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES, , 2008. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood 111: 402410.[Crossref]
  8. Manfredini V, Lazzaretti LL, Griebeler IH, Santin AP, Brandao VD, Wagner S, Castro SM, Peralba MC, Benfato MS, , 2008. Blood antioxidant parameters in sickle cell anemia patients in steady state. J Natl Med Assoc 100: 897902.[Crossref]
  9. Reid M, Badaloo A, Forrester T, Jahoor F, , 2006. In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease. Am J Physiol Endocrinol Metab 291: E73E79.[Crossref]
  10. Somjee SS, Warrier RP, Thomson JL, Ory-Ascani J, Hempe JM, , 2005. Advanced glycation end-products in sickle cell anaemia. Br J Haematol 128: 112118.[Crossref]
  11. Li SD, Su YD, Li M, Zou CG, , 2006. Hemin-mediated hemolysis in erythrocytes: effects of ascorbic acid and glutathione. Acta Biochim Biophys Sin (Shanghai) 38: 6369.[Crossref]
  12. Dumaswala UJ, Zhuo L, Mahajan S, Nair PN, Shertzer HG, Dibello P, Jacobsen DW, , 2001. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol 280: C867C873.
  13. Niihara Y, Matsui NM, Shen YM, Akiyama DA, Johnson CS, Sunga MA, Magpayo J, Embury SH, Kalra VK, Cho SH, Tanaka KR, , 2005. L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells. BMC Blood Disord 5: 4.
  14. Cunningham ML, Fairlamb AH, , 1995. Trypanothione reductase from Leishmania donovani. Purification, characterization and inhibition by trivalent antimonials. Eur J Biochem 230: 460468.[Crossref]
  15. Wyllie S, Cunningham ML, Fairlamb AH, , 2004. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani . J Biol Chem 279: 3992539932.[Crossref]
  16. Wyllie S, Fairlamb AH, , 2006. Differential toxicity of antimonial compounds and their effects on glutathione homeostasis in a human leukemia monocyte cell line. Biochem Pharmacol 71: 257267.[Crossref]
  17. Swanson DR, , 1988. Migraine and magnesium: eleven neglected connections. Perspect Biol Med 31: 526557.[Crossref]
  18. Frijters R, van Vugt M, Smeets R, van Schaik R, de Vlieg J, Alkema W, , 2010. Literature mining for the discovery of hidden connections between drugs, genes and diseases. PLoS Comput Biol 6: pii: e1000943.[Crossref]
  19. Weeber M, Vos R, Klein H, De Jong-Van Den Berg LT, Aronson AR, Molema G, , 2003. Generating hypotheses by discovering implicit associations in the literature: a case report of a search for new potential therapeutic uses for thalidomide. J Am Med Inform Assoc 10: 252259.[Crossref]
  20. Hettne KM, Weeber M, Laine ML, ten Cate H, Boyer S, Kors JA, Loos BG, , 2007. Automatic mining of the literature to generate new hypotheses for the possible link between periodontitis and atherosclerosis: lipopolysaccharide as a case study. J Clin Periodontol 34: 10161024.[Crossref]
  21. Kuhn M, von Mering C, Campillos M, Jensen LJ, Bork P, , 2008. STITCH: interaction networks of chemicals and proteins. Nucleic Acids Res 36: D684D688.[Crossref]
  22. Baral C, Gonzalez G, Gitter A, Teegarden C, Zeigler A, Joshi-Topé G, , 2007. CBioC: beyond a prototype for collaborative annotation of molecular interactions from the literature. Comput Syst Bioinformatics Conf 6: 381384.[Crossref]
  23. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M, , 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res 32: D277D280.[Crossref]
  24. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS, , 2011. DrugBank 3.0: a comprehensive resource for “omics” research on drugs. Nucleic Acids Res 39: D1035D1041.[Crossref]
  25. Davis AP, King BL, Mockus S, Murphy CG, Saraceni-Richards C, Rosenstein M, Wiegers T, Mattingly CJ, , 2011. The Comparative Toxicogenomics Database: update 2011. Nucleic Acids Res 39: D1067D1072.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.11-0683
Loading
/content/journals/10.4269/ajtmh.2012.11-0683
Loading

Data & Media loading...

  • Received : 01 Nov 2011
  • Accepted : 08 Mar 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error